SchroderJapan Growth - Director/PDMR Shareholding
06/03/2023 13:57
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230306:nRSF0427Sa&default-theme=true
RNS Number : 0427S Schroder Japan Growth Fund PLC 06 March 2023
Schroder Japan Growth Fund plc
Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them
Dr Philip Kay was notified by his broker of a delay to his ISA subscription
which caused him to be disadvantaged by 66 units, this was back dated through
an automated corrective share purchase on 28 February 2023 after the Company
had entered a closed period.
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Dr Philip Kay
2 Reason for the notification
a) Position/status Director
b) Initial notification/amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Schroder Japan Growth Fund plc
b) LEI 549300SSPK3AXNJOC673
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of £0.10 each
Identification code
ISIN: GB0008022849
b) Nature of the transaction Share purchase
c) Price(s) and volume(s)
Price(s) Volume(s)
£ 2.10 66
d) Aggregated information
66
- Aggregated volume
£139.29
- Price
e) Date of the transaction 28 February 2023 notified to the issuer on 6 March 2023
f) Place of the transaction (XLON) London Stock Exchange
d)
Aggregated information
- Aggregated volume
- Price
66
£139.29
e)
Date of the transaction
28 February 2023 notified to the issuer on 6 March 2023
f)
Place of the transaction
(XLON) London Stock Exchange
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHBXGDXLUGDGXL